Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There you go sal. He's using twitter to help oncs. Go thank him. :).
$1.50-3.00 with the incredible opportunity to buy back in again after another huge drop. That's my plan. Then hold a core position if they truly knock it out of the park.
If you are referring to my comment as a Pollyanna attitude, that's pretty lame. Listen, big money uses MM's to accumulate shares. It's right on there advertising. They have been shorting this shock to death to bring the price down. This same dynamic happened in INO, rnn, cprx, AMBS, etc before big runs happened. It's a total game, but a very lucrative one.
Absolutely! Big money wants in. There is a reason.
This flush out is good. The last 3 days we have had 10-12 million total shares change hands. The reversal will be hard and fast when it happens.
I'm being sarcastic! A lot of people here were blaming his lack of leadership for the slide (complete bs) and were complaining. So, if he gets blamed for the slide he should get congratulated for the recovery. :)
Ok so everybody go to Punit's twitter page and tell him thanks for the reversal. Goes both ways.
Well, I think we have found support finally.
I really enjoy your posts and we think the same. However, the one difference between rnn and INO is that ONCS has pending catalysts stacking up on each other. With rnn and INO, they both ran on no news several months after presenting great clinical results. Here, we have a similar dynamic where oncs presented great data at ASCO and we are now 1 1/2 months removed. However, this dynamic is combined with several other data releases, trial starts, etc. Will make for an interesting ride.
All of you who are worrying right now need to go and at the following charts: INO, AMBS, cprx, rnn, etc. All of them had significant drops in price before the big pps increases occurred. Most of them had the same direct placement and everyone was worried when the price went down for NO reason. This is how the game is played. I think we are close. Big money is systematically removing even the most loyal longs to get shares cheap and they are winning.
Next wed ONCS is presenting for the first time data that supports the very hypothesis of converting non-responders into responders. This is the very hypothesis they have been saying ever since pierce arrived. This is the data that has the potential to change the approach to cancer research. This is what we have been waiting for and it's so close. Go get a beer, hang out with your kids and watch oncs "shock" the world.
Absolutely spot on. That's exactly what I'm planning to do. INO went to $3.00 and then back to 1.20 within 3 days.
Awesome buy bud. I was one day too early.
The more flushing that occurs, the harder and more violent the rebound will be. Buy as much as you can friends. Awesome opportunity!
It's all good fur. I bought a bunch more before ASCO at .72 for a short term play and then didn't sell. By September it won't matter.
Got me filled. Nice. Keep buying guys. If you thought the low .60's were a gift, than this is just free money. Got 16,000 more at .52.
I got bids for 16000 shares at .52. We will see.
Good video. Nice find.
As I've said several times now. This stock is being and needed to be gutted before the big action happens. When they let it go, it will be a greater increase than we realize.
This is a great company. Everything is in place to knock this thing out if the park.
Follow the money:
1. Institutions wanted in and are in.
2. MM's working really hard to keep the price down for big boys to scoop up more shares. Tons of shares have been bought in the 50's and 60's lately.
3. Bashers are showing up in droves.
Take a deep breath and hold on. Your true metal as an investor is when you hold shares you know are valuable in your head but the market in devalues them. An idiot can hold when the price is going up.
Don't know but definitely after ASCO
For those of you with ADD. The Merck referance is at 5:02 of the video. The real question is why is Punit is New York. Let the speculation begin. . .
Ya, decent interview. The interviewer is an idiot though. Things you should have down before you interview someone: Be sure how to pronounce the CEO's name and the company name you are interviewing.
Interview with the Street of Punit Dhillon:
http://newtothestreet.tv/interview/punit-dhillon-oncosec
Well, it's about time furbush!!!!!
Thinking the same thing.
Thanks
For those who don't have level 2, what did it show you?
Looks like investors don't want to get caught with their pants down if news comes out. Big buys at the end of each day this week.
I've been out most of the day but it looks like we got some great buys and some decent volume.
I'm really curious about new data that might be released tomorrow or Thursday (similar to the PEGS conference). Exciting times.
Have a great 4th if July to everyone. Next week should be exciting.
This is heating up.
For the love if god, just keep going up.
I wrote a long explanation with a ton of links a while back. Basically, the 10th rule only applies if ownership is more than 10% or where the ownership isn't passive. It is confusing.
Awesome, detailed post. Welcome to the board.
Further, the initial press release didn't allude to any data and then data was presented and PR'd the day if the discussion.
By the way, don't be surprise if oncs releases data next week as well. The last "discussion" was PEGS and they presented new mouse data. The audience is a bunch of researchers and clinicians. Seems like the right group to discuss new findings.
I believe we are going to see one of two things:
1. The intra-tumoral immunogenicity results from ep+ il-12 from the melanoma trial(s). I'm referring to the details/slides Punit alluded to at marcum.
2. Going to see new data from mouse trials from the Seattle and /or San Diego labs isolating these questions further.
Cool. You just might be the firm hero by fall.
Did your firm buy back in yet?